We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Website: https://lesi-org.zoom.us/meeting/register/tZUtf-6pqjorGdx1DFfg020SpAlXsVy1Vk_p
In an era marked by unprecedented advancements in medical science and technology, ensuring equitable access to life-saving medicines remains a global imperative. The equitable licensing of medicines and biologics plays a pivotal role in addressing the complex challenges that limit access to essential medications across the world. This panel discussion brings together experts from diverse backgrounds to explore the multifaceted dimensions of equitable licensing considerations for access to medicines.
The panel will delve into various aspects of equitable licensing, including the legal, ethical, economic, and social dimensions. Some key themes to be addressed include the role of intellectual property rights, compulsory licensing, technology transfer, and international agreements in shaping the availability and affordability of medicines. Additionally, the discussion will explore how equitable licensing can bridge the gap between research and development, production, and global distribution of pharmaceuticals.
Ultimately, this panel aims to foster a robust dialogue on equitable licensing as a means to not only overcome barriers to medicine access but also as a driver for innovation, collaboration, and the pursuit of health equity. It invites participants to consider the ethical imperative of ensuring that the benefits of medical progress are shared by all, regardless of geographic location or economic status.
